|Articles|May 1, 1998

May 1998
Volume 4
Issue 5

Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Gastropathy: Clinical and Economic Implications of a Single-Tablet Formulation of Diclofenac/Misoprostol

Author(s)Jay L. Goldstein, MD, Leanne R. Larson, MHA, Beverly D. Yamashita, RN

Download PDF: Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Gastropathy: Clinical and Economic Implications of a Single-Tablet Formulation of Diclofenac/Misoprostol

Articles in this issue

about 28 years ago

Article

Experience with a Managed Care Approach to HIV Infection: Effectiveness of an Interdisciplinary Team

about 28 years ago

Article

Regulating the Financial Incentives Facing Physicians in Managed Care Plans

about 28 years ago

Article

Evaluation of "Solitary" Thyroid Nodules in a Community Practice: A Managed Care Approach

about 28 years ago

Article

Patient Waiting Times in a Physician's Office

about 28 years ago

Article

Infertility Services and Managed Care

about 28 years ago

Article

The development and Implementation of Normal Vaginal Delivery Clinical Pathways in a Large Multihospital Health System

about 28 years ago

Article

Nonhormonal Alternatives to Treating Menopausal Symptoms

about 28 years ago

Article

Patient Satisfaction and Quality of Life: Humanistic Outcomes

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

Orthopedic surgeon holds bone x-ray | Image Credit: © tippapatt - stock.adobe.com

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

ByHannah I. Travers, MD,Mikhail Kuznetsov, MD,John Mazzocco, MD,Nicholas Pagani, MD,Tricia Ide, DNP, RN,Brian L. Hollenbeck, MD,Eric L. Smith, MD

June 3rd 2026

Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Gastropathy: Clinical and Economic Implications of a Single-Tablet Formulation of Diclofenac/Misoprostol

Articles in this issue

Related Content

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

Trending on AJMC

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD

AI Reshaping Diabetes Care From Nutrition to Clinical Decisions

Contributor: How to Pair Data With Clinical Care to Manage Health Care Costs

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD